Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. Pharmacodynamic Assays for Cancer Therapeutics.                    

*Date:*                         October 6, 2009.                    

*Time:*                         11 a.m. to 1:30 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room # 210, Rockville, MD 20852. (Telephone Conference Call).                    

*Contact Person:*                         Thomas M Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892. 301-594-9582.                         *vollbert@mail.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. R13 Conference Grants Review.                    

*Date:*                         October 29, 2009.                    

*Time:*                         1 p.m. to 5 p.m.                              ( print page 49384)    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, 8041, Rockville, MD 20852. (Telephone Conference Call).                    

*Contact Person:*                         Bratin K. Saha, PhD, Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8041, Bethesda, MD 20892. (301) 402-0371.                         *sahab@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. NCI Cancer Prevention Research II.                    

*Date:*                         October 30, 2009.                    

*Time:*                         10 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room # 210, Rockville, MD 20852. (Telephone Conference Call).                    

*Contact Person:*                         Irina Gordienko, PhD, Scientific Review Officer, Scientific Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 7073, Bethesda, MD 20892. 301-594-1566.                         *gordienkoiv@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. Community Clinical Oncology Programs.                    

*Date:*                         December 1-2, 2009.                    

*Time:*                         7 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Marriott Courtyard Gaithersburg Washingtonian Ctr, 204 Boardwalk Place, Gaithersburg, MD 20878.                    

*Contact Person:*                         Gerald G. Lovinger, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892-8329. 301/496-7987.                         *lovingeg@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: September 21, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-23269 Filed 9-25-09; 8:45 am]

BILLING CODE 4140-01-P